Search

Author/Creator Tataroglu Ozyukseler, Deniz

1. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Issue 1 (February 2022)

Authors:
Cil, Ibrahim; Kucukarda, Ahmet; Atcı, Muhammed Mustafa; Secmeler, Saban; Paksoy, Nail; Ferhatoglu, Ferhat; Ak, Naziye; Ayhan, Murat; Tataroglu Ozyukseler, Deniz; Onder, Arif Hakan; Avci, Okan; Oyman, Abdilkerim; Okten, Ilker Nihat; Gulturk, Ilkay; Akagunduz, Baran; Basoglu, Tugba; Cakir, Emre; Ha...
Journal:
Tumori
Issue:
Volume 108:Issue 1(2022)
Page Start:
19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer. (April 2021)

Authors:
Tataroglu Ozyukseler, Deniz; Basak, Mustafa; Ay, Seval; Koseoglu, Aygül; Arıcı, Serdar; Oyman, Abdilkerim; Sürmeli, Heves; Turan, Merve; Turan, Nedim; Odabaş, Hatice; E Yıldırım, Mahmut
Journal:
Journal of oncology pharmacy practice
Issue:
Volume 27:Number 3(2021)
Page Start:
547
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search